Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin

被引：0
|
作者：
Liwei Meng
Liming Huang
Yingchun Xu
Wei Zhang
机构：
[1] Shaoxing People’s Hospital (Shaoxing Hospital of Zhejiang University),Department of Breast and Thyroid Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Breast cancer; Interstitial pneumonitis; Pegylated liposomal doxorubicin; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 7
页数：4
相关论文
共 50 条
  • [1] Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin
    Meng, Liwei
    Huang, Liming
    Xu, Yingchun
    Zhang, Wei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 3 - 7
  • [2] Interstitial Pneumonitis after Treatment with Bevacizumab and Pegylated Liposomal Doxorubicin in a Patient with Metastatic Breast Cancer
    Huober, Jens
    Schoch, Otto
    Templeton, Arnoud
    Spirig, Christian
    Thuerlimann, Beat
    CHEMOTHERAPY, 2010, 56 (01) : 69 - 70
  • [3] Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer
    Inaba, Kanako
    Arimoto, Takahide
    Hoya, Mari
    Kawana, Kei
    Nakagawa, Shunsuke
    Kozuma, Shiro
    Taketani, Yuji
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1255 - 1257
  • [4] Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer
    Kanako Inaba
    Takahide Arimoto
    Mari Hoya
    Kei Kawana
    Shunsuke Nakagawa
    Shiro Kozuma
    Yuji Taketani
    Medical Oncology, 2012, 29 : 1255 - 1257
  • [5] Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab
    Zhou, Ting
    Shen, Qian
    Peng, Hui
    Chao, Tengfei
    Zhang, Lihong
    Huang, Liu
    Yang, Kaixiang
    Thapa, Sudip
    Yu, Shiying
    Jiang, Yongsheng
    ANNALS OF HEMATOLOGY, 2018, 97 (01) : 141 - 147
  • [6] Incidence of interstitial pneumonitis in non-Hodgkin’s lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab
    Ting Zhou
    Qian Shen
    Hui Peng
    Tengfei Chao
    Lihong Zhang
    Liu Huang
    Kaixiang Yang
    Sudip Thapa
    Shiying Yu
    Yongsheng Jiang
    Annals of Hematology, 2018, 97 : 141 - 147
  • [7] Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer
    Minisini, Alessandro M.
    Andreetta, Claudia
    Fasola, Gianpiero
    Puglisi, Fabio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 331 - 342
  • [8] Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer
    Christodoulou, Christos
    Kostopoulos, Ioannis
    Kalofonos, Haralabos P.
    Lianos, Evangelos
    Bobos, Mattheos
    Briasoulis, Evangelos
    Gogas, Helen
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Fountzilas, George
    ONCOLOGY, 2009, 76 (04) : 275 - 285
  • [9] Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission
    Mark, Michael
    Thuerlimann, Beat
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1477 - 1478
  • [10] Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission
    Michael Mark
    Beat Thürlimann
    Medical Oncology, 2012, 29 : 1477 - 1478
12345